Bevacizumab is used to treat different types of cancer, and belongs to a group of targeted therapy drugs known as monoclonal antibodies. It is also an angiogenesis inhibitor. Bevacizumab targets a protein…
Epirubicin is a widely used anthracycline chemotherapy agent, often employed in the treatment of breast cancer, leukemia, and other malignancies.MedicaPharma is proud to offer Epirubicin, one of the most essential…
Carmofur is an antineoplastic agent that has captured attention in the medical community for its potential efficacy in treating various forms of cancer. It’s marketed under different trade names, including…
In today's complex healthcare landscape, the demand for specialty medications is surging. As a leading supplier of GMP-grade active pharmaceutical ingredients, MedicaPharma is at the forefront of this transformation, offering…
As a GMP-certified supplier, we are excited to announce the recent FDA approval of a new formulation of Levodopa/Carbidopa for the treatment of Parkinson's disease. This advancement marks a significant…
In the world of veterinary medicine, the fight against bacterial infections is ongoing, and the stakes are high. For pet owners and veterinarians alike, finding effective treatments that can tackle…
IntroductionIn the ever-evolving landscape of antibiotic resistance, the emergence of vancomycin-resistant pathogens presents a significant challenge to healthcare providers. Among the arsenal of antibiotics available, Bacitracin has regained attention due…
As we’ve entered 2024, the fight against cancer continues to evolve with a wave of promising new therapies and ongoing research that offers hope for better patient outcomes. This article…
What is Upadacitinib? Upadacitinib is a disease-modifying antirheumatic medication (DMARD) that is taken orally to suppress the activity of Janus kinase (JAK)1 and to reduce the progression of rheumatoid arthritis.…
According to Market Research Intellect from the MRI Team, Vinorelbine Tartrate injection is projected to expand at a compound annual growth rate (CAGR) of 9.33% between 2024 and 2031By 2024,…
Imiquimod, an agent with antiviral and antitumor properties, encourages an immune response through the production of cytokines such as interferon-α, interleukin-6, and interleukin-8. According to a recent study presented by YCC…
According to research, Tirzepatide may reduce body weight more significantly than Semaglutide. Those using Tirzepatide at the highest dosage lost an average of 21% of their body weight throughout the…
Supplier of Special Active Pharmaceutical Ingredients (GMP)
World Wide Shipping – Get a Quick Quote Now – Small quantities in GMP available
MedicaPharma – WORLDWIDE NICHE API SPECIALIST
All materials supplied according to:
